Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Effect of rTMS on Treatment-Resistant Depression

JAMA Psychiatry; ePub 2018 Jun 27; Yesavage, et al

In a recent randomized clinical trial to determine the efficacy of repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depression (TRMD), 164 US veterans with depression showed an overall remission rate of 39%, with no significant difference between the active and sham groups. Patients with comorbid posttraumatic stress disorder (PTSD) showed the least improvement. Participants were randomized to either left prefrontal rTMS treatment (10 Hz, 120% motor threshold, 4,000 pulses/session) or to sham (control) rTMS treatment for up to 30 treatment sessions. Total participants had a mean (SD) age of 55.2 (12.4) years, 132 (80.5%) were men, and 126 (76.8%) were of white race. Of these, 81 were randomized to receive active rTMS and 83 to receive sham. Researchers found:

  • For the primary analysis of remission, there was no significant effect of treatment.
  • At the end of the acute treatment phase, 33 of 81 (40.7%) of those in the active treatment group achieved remission of depressive symptoms compared with 31 of 83 (37.4%) of those in the sham treatment group.
  • Overall, 64 of 164 (39.0%) of the participants achieved remission.

Citation:

Yesavage JA, Fairchild JK, Mi Z, et al, for the VA Cooperative Studies Program Study Team. [Published online ahead of print June 27, 2018]. JAMA Psychiatry. doi:10.1001/jamapsychiatry.2018.1483.

This Week's Must Reads

MMI a Valid Tool for Cognitive Training Intervention, Schizophr Res; ePub 2018 Dec 21; Hansen, et al

Targeted Auditory Training in Schizophrenia Assessed, Int J Psychophysiol; ePub 2018 Dec 29; Roach, et al

Brain Anomalies in FDRs of Those with Schizophrenia, Schizophr Bull; ePub 2018 Dec 28; de Zwarte, et al

Auditory Deficits in Persons with Schizophrenia, Schizophr Res; ePub 2019 Jan 18; Medalia, et al

Negative Symptom Domains in Schizophrenia and BD, Schizophr Bull; ePub 2019 Jan 14; Strauss, et al

Must Reads in Depression

ED Recovery Linked with MDD Recovery 22 Years Later, Compr Psychiatry; 2019 Apr; Keshishian, et al

Neurotrophic Factor and Suicidal Ideation in MDD, Psychiatry Res; 2019 Mar; Khan, Wu, et al

Reduced Immunity to Measles in Adults with MDD, Psych Med; 2019 Jan; Ford, Yolken, Dickerson, et al

Social Network Site Usage Linked to Depression, J Affect Disord; ePub 2019 Jan 27; Yoon, et al

Differentiating PTSD from Anxiety/Depression, Depress Anxiety; ePub 2019 Jan 25; Barbano, et al